Youdim MB - Search Results

1

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB. Jellinger K, et al. Among authors: youdim mb. J Neural Transm Park Dis Dement Sect. 1990;2(4):327-40. doi: 10.1007/BF02252926. J Neural Transm Park Dis Dement Sect. 1990. PMID: 2078310

2

Blood to brain iron uptake in one rhesus monkey using [Fe-52]-citrate and positron emission tomography (PET): influence of haloperidol.

Leenders KL, Antonini A, Schwarzbach R, Smith-Jones P, Reist H, Ben-Shachar D, Youdim M, Henn V. Leenders KL, et al. J Neural Transm Suppl. 1994;43:123-32. J Neural Transm Suppl. 1994. PMID: 7884394

3

Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.

Sofic E, Salkovic-Petrisic M, Tahirovic I, Sapcanin A, Mandel S, Youdim M, Riederer P. Sofic E, et al. J Neural Transm (Vienna). 2015 Apr;122(4):559-64. doi: 10.1007/s00702-014-1307-y. Epub 2014 Sep 25. J Neural Transm (Vienna). 2015. PMID: 25252744

4

Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease.

Youdim MB. Youdim MB. J Neural Transm Suppl. 1986;22:91-105. J Neural Transm Suppl. 1986. PMID: 3097263 Review.

5

Impaired iron homeostasis in Parkinson's disease.

Double KL, Gerlach M, Youdim MB, Riederer P. Double KL, et al. Among authors: youdim mb. J Neural Transm Suppl. 2000;(60):37-58. doi: 10.1007/978-3-7091-6301-6_3. J Neural Transm Suppl. 2000. PMID: 11205155 Review.

6

New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline.

Gerlach M, Desser H, Youdim MB, Riederer P. Gerlach M, et al. Among authors: youdim mb. J Neural Transm Suppl. 1996;48:7-21. doi: 10.1007/978-3-7091-7494-4_2. J Neural Transm Suppl. 1996. PMID: 8988458 Review.

7

Is selegiline neuroprotective in Parkinson's disease?

Gerlach M, Youdim MB, Riederer P. Gerlach M, et al. Among authors: youdim mb. J Neural Transm Suppl. 1994;41:177-88. doi: 10.1007/978-3-7091-9324-2_24. J Neural Transm Suppl. 1994. PMID: 7931225 Review.

8

The enigma of neuromelanin in Parkinson's disease substantia nigra.

Youdim MB, Ben-Shachar D, Riederer P. Youdim MB, et al. J Neural Transm Suppl. 1994;43:113-22. J Neural Transm Suppl. 1994. PMID: 7884393 Review.

9

Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?

Youdim MB, Ben-Shachar D, Riederer P. Youdim MB, et al. Acta Neurol Scand Suppl. 1989;126:47-54. doi: 10.1111/j.1600-0404.1989.tb01782.x. Acta Neurol Scand Suppl. 1989. PMID: 2618593

10

Potential sources of increased iron in the substantia nigra of parkinsonian patients.

Gerlach M, Double KL, Youdim MB, Riederer P. Gerlach M, et al. Among authors: youdim mb. J Neural Transm Suppl. 2006;(70):133-42. doi: 10.1007/978-3-211-45295-0_21. J Neural Transm Suppl. 2006. PMID: 17017520 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results